Begg’s and Egger’s tests showed no publication bias between ESRα Pvull, ESRα Xbal, ESRβ Alul, and ESRβ Rsal polymorphisms and prostate cancer (Figure 4). Here, ESR2 is linked to prostate carcinoma.